Madison Vaccines Announces The Appointment Of Michael Richman To Its Board Of Directors
5/14/2014 7:24:24 AM
Madison Vaccines Incorporated (MVI), a clinical stage biopharmaceutical company focused on advancing innovative therapies for prostate cancer, today announced the appointment of Michael Richman to its Board of Directors. Mr. Richman has almost 30 years’ experience working in pharmaceutical research and business development.
Help employers find you! Check out all the jobs and post your resume.
comments powered by